JP2009535021A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535021A5
JP2009535021A5 JP2009506889A JP2009506889A JP2009535021A5 JP 2009535021 A5 JP2009535021 A5 JP 2009535021A5 JP 2009506889 A JP2009506889 A JP 2009506889A JP 2009506889 A JP2009506889 A JP 2009506889A JP 2009535021 A5 JP2009535021 A5 JP 2009535021A5
Authority
JP
Japan
Prior art keywords
sequence
antibody
seq
identity
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009506889A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009535021A (ja
JP5431920B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CH2007/000202 external-priority patent/WO2007124610A1/en
Publication of JP2009535021A publication Critical patent/JP2009535021A/ja
Publication of JP2009535021A5 publication Critical patent/JP2009535021A5/ja
Application granted granted Critical
Publication of JP5431920B2 publication Critical patent/JP5431920B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009506889A 2006-04-28 2007-04-27 受容体チロシンキナーゼalkの細胞外ドメインに結合する抗体 Expired - Fee Related JP5431920B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79583106P 2006-04-28 2006-04-28
US60/795,831 2006-04-28
PCT/CH2007/000202 WO2007124610A1 (en) 2006-04-28 2007-04-27 Antibodies binding to the extracellular domain of the receptor tyrosine kinase alk

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013112192A Division JP5911821B2 (ja) 2006-04-28 2013-05-28 受容体チロシンキナーゼalkの細胞外ドメインに結合する抗体

Publications (3)

Publication Number Publication Date
JP2009535021A JP2009535021A (ja) 2009-10-01
JP2009535021A5 true JP2009535021A5 (enExample) 2011-07-28
JP5431920B2 JP5431920B2 (ja) 2014-03-05

Family

ID=38515389

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009506889A Expired - Fee Related JP5431920B2 (ja) 2006-04-28 2007-04-27 受容体チロシンキナーゼalkの細胞外ドメインに結合する抗体
JP2013112192A Active JP5911821B2 (ja) 2006-04-28 2013-05-28 受容体チロシンキナーゼalkの細胞外ドメインに結合する抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013112192A Active JP5911821B2 (ja) 2006-04-28 2013-05-28 受容体チロシンキナーゼalkの細胞外ドメインに結合する抗体

Country Status (16)

Country Link
US (3) US7902340B2 (enExample)
EP (2) EP2013236B1 (enExample)
JP (2) JP5431920B2 (enExample)
KR (1) KR101457228B1 (enExample)
CN (1) CN101443361B (enExample)
AU (1) AU2007246144B2 (enExample)
BR (1) BRPI0710971A2 (enExample)
CA (1) CA2650822C (enExample)
DK (1) DK2013236T3 (enExample)
ES (1) ES2547248T3 (enExample)
IL (1) IL194752A0 (enExample)
MX (1) MX2008013705A (enExample)
NZ (1) NZ572248A (enExample)
PL (1) PL2013236T3 (enExample)
RU (1) RU2460540C2 (enExample)
WO (1) WO2007124610A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2013236T3 (pl) * 2006-04-28 2015-12-31 Delenex Therapeutics Ag Przeciwciała łączące się z zewnątrzkomórkową domeną receptora kinazy tyrozynowej ALK
WO2008131575A2 (en) * 2007-04-27 2008-11-06 Esbatech Ag Anti-alk antibodies suitable for treating metastatic cancers or tumors
US20110206691A1 (en) * 2008-02-15 2011-08-25 Mosse Yael P Methods and Compositions for Treating Neuroblastoma
WO2009103061A2 (en) * 2008-02-15 2009-08-20 The Children's Hospital Of Philadelphia Methods and compositions for identifying, diagnosing, and treating neuroblastoma
RU2653753C1 (ru) 2008-06-25 2018-05-14 ИЭсБиЭйТЕК, ЭН АЛЬКОН БАЙОМЕДИКАЛ РИСЕРЧ ЮНИТ ЭлЭлСи СТАБИЛЬНЫЕ И РАСТВОРИМЫЕ АНТИТЕЛА, ИНГИБИРУЮЩИЕ TNFα
CN104004094B (zh) 2008-06-25 2017-09-22 艾斯巴技术-诺华有限责任公司 使用通用抗体构架进行的兔抗体的人源化
AR083495A1 (es) 2010-10-22 2013-02-27 Esbatech Alcon Biomed Res Unit Anticuerpos estables y solubles
MX2014002289A (es) 2011-08-26 2015-03-20 Merrimack Pharmaceuticals Inc Anticuerpos fc especificos en tandem.
EP2773651B1 (en) 2011-11-03 2020-12-23 The Trustees of the University of Pennsylvania Isolated b7-h4 specific compositions and methods of use thereof
MX2015011712A (es) 2013-03-06 2016-04-04 Merrimack Pharmaceuticals Inc Anticerpos biespecificos fc en fila anti-c-met.
CN104861069B (zh) * 2014-02-21 2018-12-18 无锡傲锐东源生物科技有限公司 针对间变性淋巴瘤激酶的单克隆抗体1a4及其用途
WO2015184231A2 (en) * 2014-05-30 2015-12-03 Kolltan Pharmaceuticals, Inc. Regulators of anaplastic lymphoma kinase and uses thereof
WO2017035430A2 (en) * 2015-08-27 2017-03-02 Kolltan Pharmaceuticals, Inc. Anti-alk antibodies and methods for use thereof
CA2940470C (en) 2015-09-18 2019-08-20 Signpath Pharma Inc. Treatment for glioblastoma
MX2018004515A (es) * 2015-10-13 2019-04-15 Eureka Therapeutics Inc Agentes de anticuerpo especificos para cd19 humano y usos de los mismos.
WO2017070608A1 (en) 2015-10-23 2017-04-27 Eureka Therapeutics, Inc. Antibody/t-cell receptor chimeric constructs and uses thereof
WO2017147408A1 (en) * 2016-02-25 2017-08-31 The Regents Of The University Of California Methods for the treatment of hematologic cancer
CN110741016A (zh) 2017-04-26 2020-01-31 优瑞科生物技术公司 嵌合抗体/t-细胞受体构筑体及其用途
WO2019157342A1 (en) * 2018-02-09 2019-08-15 Acceleron Pharma Inc. Methods for treating heterotopic ossification
IT201800009282A1 (it) * 2018-10-09 2020-04-09 Metis Prec Medicine Sb Srl Nuovo agente terapeutico per il trattamento di un tumore e/o metastasi
CN113960313B (zh) * 2021-12-22 2022-04-12 上海思路迪医学检验所有限公司 一种外泌体alk融合蛋白磁免疫化学发光检测试剂盒

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US21505A (en) * 1858-09-14 Improvement in bullet-machines
US5529925A (en) 1993-12-03 1996-06-25 St. Jude Children's Research Hospital Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma
US6696548B2 (en) * 1993-12-03 2004-02-24 St. Jude Children's Research Hospital Antibodies for recognition of alk protein tyrosine/kinase receptor
WO1997008320A1 (en) 1995-08-18 1997-03-06 Morphosys Gesellschaft Für Proteinoptimierung Mbh Protein/(poly)peptide libraries
CA2267620A1 (en) 1996-07-16 1998-01-22 Andreas Pluckthun Immunoglobulin superfamily domains and fragments with increased solubility
JPH1116250A (ja) 1997-06-20 1999-01-22 Pioneer Electron Corp 情報再生システム
EP1242457B1 (en) * 1999-12-28 2004-08-11 Esbatech AG Intrabodies with defined framework that is stable in a reducing environment and applications thereof
AU2001266876B2 (en) 2000-06-14 2006-08-31 Georgetown University Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders
CA2421447C (en) 2000-09-08 2012-05-08 Universitat Zurich Collections of repeat proteins comprising repeat modules
EP2332989B1 (en) * 2002-05-22 2015-04-01 ESBATech, an Alcon Biomedical Research Unit LLC Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
US7888485B2 (en) 2003-03-26 2011-02-15 Georgetown University Anti-pleiotrophin antibodies and methods of use thereof
EP1789552A2 (en) 2004-08-10 2007-05-30 Institute for Multiple Myeloma and Bone Cancer Research Methods of regulating differentiation and treating of multiple myeloma
PL2013236T3 (pl) * 2006-04-28 2015-12-31 Delenex Therapeutics Ag Przeciwciała łączące się z zewnątrzkomórkową domeną receptora kinazy tyrozynowej ALK

Similar Documents

Publication Publication Date Title
JP2009535021A5 (enExample)
TWI713942B (zh) 與集落刺激因子1受體(csf1r)結合之抗體類
JP2022037133A (ja) 改良された血清アルブミン結合剤
JP2020023523A5 (enExample)
RU2008146922A (ru) Антитела, связывающиеся с внеклеточным доменом тирозинкиназного рецептора (alk)
JP2010535012A5 (enExample)
JP6681433B2 (ja) P2x7受容体アンタゴニスト及びアゴニスト
JP2020501531A5 (enExample)
CN108473563B (zh) 改进的tnf结合剂
JP2010511388A5 (enExample)
JP2011046732A5 (enExample)
JP2016507523A5 (enExample)
JP2019526273A5 (enExample)
JP2015509097A5 (enExample)
JP2017526339A5 (enExample)
JP2012530496A5 (enExample)
JP2011509245A5 (enExample)
PE20141564A1 (es) Moleculas de union para bcma y cd3
JP2013519364A5 (enExample)
NZ602892A (en) Antibodies that bind human cd27 and uses thereof
JP2014526898A5 (enExample)
JP2016538830A5 (enExample)
JPWO2021139777A5 (enExample)
JP2012034692A5 (enExample)
HRP20150439T1 (hr) Protutijela za humani angiopoietin 2